• Blood Test for Toxic Amyloid May Detect Alzheimer’s 8 Years Before Symptoms, Study Says
  • ‘Prime of Life Brain Initiative’ Targets Neurodegenerative Diseases
  • #AAN2018 – PRIME Trial Data Show Long-term Benefits of Aducanumab in Early Alzheimer’s
  • #AAN2018: New Data Largely Supports Memantine Combo Easing Alzheimer’s Symptoms
  • #AAN2018 – Early Data Supports Clinical Trial Now Testing IONIS-MAPTRx in Alzheimer’s Patients
  • Chronic Exposure to Caffeine Worsened Symptoms in Alzheimer’s Mouse Model
  • Researchers Using Natural Compound to ‘Beet’ Alzheimer’s Progression
  • Spanish Regulators Approve Phase 2 Trial of Oryzon’s Alzheimer’s Therapy
  • Increasing the Activity of Certain Type of Nerve Cell Restores Cognition, Mouse Study Shows
  • Lyft Volunteers to Transport Alzheimer’s Patients to and from Clinical Trial Sites
  • Niagen Treatment Leads to Improvements in Alzheimer’s Mouse Model, Study Reports
  • Elayta Shows Potential for Improving Brain Cell Activity in Alzheimer’s, Trial Results Show